Lantern Pharma Inc. Common Stock LTRN
$2.63
-0.75%
at last close
Financials (TTM)
- Revenue
- —
- Net Income
- $-15,911,826
- Net Margin
- —
- Return on Equity
- -461.79%
- Debt-to-Equity
- —
- P/E Ratio
- —
- Price / Book
- 9.74
- Price / Sales
- —
Over the trailing twelve months, Lantern Pharma Inc. Common Stock generated revenue of — and net income of $-15,911,826.
Key Stats
- Last Close
- $2.63
- Market Cap
- $33.56 million
- 52-Week Range
- $1.11 – $5.74
- Average Volume
- 142K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.